NASDAQ:MRKR | Free Cash Flow | Marker Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.4M
2025-12-31-$1.9M
2025-03-31-$5.5M
2024-12-31-$4.7M
2024-03-31-$3.84M
2023-12-31-$2.37M
2023-03-31-$5.89M
2022-12-31-$6.31M
2022-03-31-$12.23M
2021-12-31-$4.86M
2021-03-31-$8.1M
2020-12-31-$5.5M
2020-03-31-$4.1M$99,821.00-$4.2M
2019-12-31-$4.56M$12,862.00-$4.57M
2019-03-31-$3.88M$223,126.00-$4.1M
2018-12-31-$6.16M$147,668.00-$6.31M
2018-03-31-$2.35M$0.00-$2.35M
2017-12-31-$2.48M
2017-03-31-$1.92M
2016-12-31-$1.75M
2016-03-31-$829,763.00
2015-12-31-$850,965.00
2015-03-31-$1.01M
2014-12-31-$669,201.00
2014-03-31-$372,954.00
2013-12-31$59,974.00
2013-03-31-$471,294.00
2012-03-31-$332,383.00
2011-12-31-$433,138.00
2011-03-31-$404,418.00
2010-12-31-$33,337.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$12.01M
2024-12-31-$10.91M
2023-12-31-$16.44M
2022-12-31-$26.97M
2021-12-31-$27.28M
2020-12-31-$20.03M
2019-12-31-$18.28M$374,983.00-$18.66M
2018-12-31-$14.48M$147,668.00-$14.63M
2017-12-31-$8.44M$0.00-$8.44M
2016-12-31-$6.51M
2015-12-31-$4.34M
2014-12-31-$2.19M
2013-12-31-$694,583.00
2011-12-31-$1.31M
2010-12-31-$925,041.00